Intrinsic Value of S&P & Nasdaq Contact Us

CollPlant Biotechnologies Ltd. CLGN

NASDAQ Global Market

SharesGrow Score
51/100
2/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$12.50
+3557.1%

CollPlant Biotechnologies Ltd. (CLGN) current share price is $0.34. The gold spot price is $4,825.20 per troy ounce. Using the formula: CLGN in gold = $0.34 × 31.1035 ÷ $4,825.20 = 0.0022 grams of gold per share.

The Real Wealth Growth Rate measures the Compound Annual Growth Rate (CAGR) of CLGN when denominated in gold. A positive rate means the stock has outperformed gold as a store of value, while a negative rate indicates gold has been a better wealth preserver than holding CLGN shares over the measured period.

CLGN in US Dollars
Gold in US Dollars
CLGN in Gold (grams per share)

Real Wealth Growth Rate

CLGN
Computing…

"Real Wealth Growth Rate" measures the annualised compound growth rate (CAGR) of a stock when priced in gold — hard money that cannot be printed. A positive value means genuine wealth creation. A negative value means purchasing power is shrinking, even if the dollar price rises.

Step 1 — Express share price in grams of gold
$$\text{CLGN}_{\text{gold}}(t) = \frac{P_{\text{CLGN}}(t) \times 31.1035}{P_{\text{gold}}(t)}$$
$P_\text{CLGN}$ = stock price in USD, $P_\text{gold}$ = gold spot in USD/troy oz, $31.1035$ = grams per troy ounce.
Step 2 — Real Wealth Growth Rate (CAGR in gold terms)
$$\text{Real Wealth Growth Rate} = \left(\frac{\text{CLGN}_{\text{gold}}^{(T)}}{\text{CLGN}_{\text{gold}}^{(0)}}\right)^{\!\frac{1}{T}} - 1$$
$\text{CLGN}_\text{gold}^{(0)}$ = initial gold-price, $\text{CLGN}_\text{gold}^{(T)}$ = current gold-price, $T$ = number of years. A positive result means the stock outpaces gold.

Real Wealth Growth Rate Rankings — 20 Years

Computing…

People Also View

MRUS
MRUS
Merus N.V.
$90.00
+0.00%
CRNX
CRNX
Crinetics Pharmaceuticals, Inc.
$39.77
+0.05%
NAMS
NAMS
NewAmsterdam Pharma Company N.V.
$34.01
-1.25%
VCEL
VCEL
Vericel Corporation
$35.37
+0.65%
GLUE
GLUE
Monte Rosa Therapeutics, Inc.
$18.23
+4.17%
IKNA
IKNA
Ikena Oncology, Inc.
$17.16
+1,152.55%
PRTC
PRTC
PureTech Health plc
$18.25
+2.13%
KROS
KROS
Keros Therapeutics, Inc.
$11.71
+1.39%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message